DelveInsight Business Research LLP

DelveInsight’s “Argininosuccinic Aciduria Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of the Argininosuccinic Aciduria, historical and forecasted epidemiology as well as the Argininosuccinic Aciduria market trends in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom) and Japan.

Argininosuccinic Aciduria  Overview

Argininosuccinic aciduria is an inherited disorder that causes ammonia to accumulate in the blood. Ammonia, which is formed when proteins are broken down in the body, is toxic if the levels become too high. The nervous system is especially sensitive to the effects of excess ammonia

Argininosuccinic Aciduria  Epidemiology Insights

Argininosuccinic aciduria occurs in approximately 1 in 70,000 to 218,000 newborns. Most cases of this condition are detected shortly after birth by newborn screening. In the US, there are less than 5,000 with this disease.

Got queries? Click here to know more about Argininosuccinic Aciduria Market Landscape

The Report Covers the Argininosuccinic Aciduria  Epidemiology, Segmentated by –

• Argininosuccinic Aciduria prevalent cases 

• Argininosuccinic Aciduria incident cases 

• Argininosuccinic Aciduria treatment cases 

Argininosuccinic Aciduria  Market Outlook 

The Argininosuccinic Aciduria market outlook of the report helps to build a detailed comprehension of the historical, current, and forecasted Argininosuccinic Aciduria market trends by analyzing the impact of current Argininosuccinic Aciduria therapies on the market, unmet needs, drivers and barriers, and demand for better technology.

This segment gives a thorough detail of the Argininosuccinic Aciduria market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion, and exclusion criteria, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated Argininosuccinic Aciduria market data are presented with relevant tables and graphs to give a clear view of the market at first sight.

According to DelveInsight, the Argininosuccinic Aciduria market in 7MM is expected to witness a major change in the study period 2019-2032

Key Companies in the Argininosuccinic Aciduria Market:

• Promethera Biosciences

• Evox Therapeutics 

• Acer Therapeutics

• Horizon Therapeutics

And many others 

Argininosuccinic Aciduria  Therapies Covered and Analyzed in the Report:

• ACER-001

• PRX ASL 

• Ravicti 

• PRX ASL 

And many others 

Learn more about Argininosuccinic Aciduria Key Companies 

Table of Contents 

1. Key Insights 

2. Argininosuccinic Aciduria Introduction 

3. Executive Summary of Argininosuccinic Aciduria   

4. Disease Background and Overview

5. Epidemiology and patient population

6. Argininosuccinic Aciduria  Emerging Therapies

7. Argininosuccinic Aciduria  Market Outlook

8. Market Access and Reimbursement of Therapies

9. Market Drivers 

10. Market Barriers 

11. Appendix

12. Argininosuccinic Aciduria  Report Methodology

13. DelveInsight Capabilities

14. Disclaimer

Learn more about the detailed offerings of the report Argininosuccinic Aciduria Market Outlook

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Adya Kaul
Email: Send Email
Phone: 919650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/consulting/due-diligence-services